Live-attenuated measles, mumps, and rubella booster vaccine in children diagnosed with rheumatic disease: A single-center study
To evaluate the safety profile of measles, mumps and rubella (MMR) booster in children diagnosed with rheumatic diseases receiving biological agents. The study included retrospective safety data of children administered MMR booster dose receiving biologics or biologics with methotrexate. The files o...
Gespeichert in:
| Veröffentlicht in: | European journal of pediatrics 2023-01, Vol.182 (1), p.135-140 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 140 |
|---|---|
| container_issue | 1 |
| container_start_page | 135 |
| container_title | European journal of pediatrics |
| container_volume | 182 |
| creator | Çakmak, Figen Akgün, Özlem Demirkan, Fatma Gül Tanatar, Ayşe Kayaalp, Gülşah Kavrul Keskindemirci, Gonca Guliyeva, Vafa Ömeroğlu, Rukiye Eker Gökçay, Emine Gülbin Ayaz, Nuray Aktay |
| description | To evaluate the safety profile of measles, mumps and rubella (MMR) booster in children diagnosed with rheumatic diseases receiving biological agents. The study included retrospective safety data of children administered MMR booster dose receiving biologics or biologics with methotrexate. The files of 182 patients were accessed from the pediatric rheumatology biological therapy archive, and the vaccination status of these children was obtained by accessing electronic records. Of 182 patients, 14 patients were vaccinated with MMR booster dose. Thirteen of the patients were followed up with a diagnosis of juvenile idiopathic arthritis and one with colchicine-resistant familial Mediterranean fever. None of the patients had disease exacerbation after vaccination, and three patients had mild side effects consisting of rash, angioedema, joint pain, and fatigue.
Conclusion
: This study supports the data regarding evidence of the safety of MMR booster dose administration in children with rheumatic diseases receiving bDMARDs.
What is Known:
• MMR booster is avoided in immunocompromised pediatric patients receiving bDMARDs except in specific conditions.
What is New:
• The MMR booster dose may be safe in children with PedRD receiving bDMARDs or bDMARDs with MTX. These bullets can be added to the manuscript. |
| doi_str_mv | 10.1007/s00431-022-04646-x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2724584250</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2762536258</sourcerecordid><originalsourceid>FETCH-LOGICAL-c349t-81e312930e893e3d6020f8a428addfecd3d06861ae0205dff46d35d1e27226ba3</originalsourceid><addsrcrecordid>eNp9kTtvFDEUhS1ERB7wByiQJRqKOPg13lm6KEoAaSUaqC2vfWfX0Yxn8bVDUvHX8bLhIQqqa-l85_jah5CXgl8IzhdvkXOtBONSMq6NNuz-CTkRWkkm-MI8_et8TE4Rb3kzLUX_jBwrI6XWypyQ76t4B8yVAqm6AoFO4HAEPKdTnXZtuBRormsYR0fX84wFMr1z3scENCbqt3EMGRIN0W3SjC3hWyxbmrdQJ1eibwK2SHhHLynGtBmBeUj7FCw1PDwnR4MbEV48zjPy5eb689UHtvr0_uPV5Yp5pZeF9QKUkEvFoV8qUMFwyYfeadm7EAbwQQVueiMcNKELw6BNUF0QIBdSmrVTZ-TNIXeX568VsNgpot-_KsFc0TZOd72WHW_o63_Q27nm1LZrlJFd-7yub5Q8UD7PiBkGu8txcvnBCm739dhDPbbVY3_WY--b6dVjdF1PEH5bfvXRAHUAsElpA_nP3f-J_QE0CJwx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2762536258</pqid></control><display><type>article</type><title>Live-attenuated measles, mumps, and rubella booster vaccine in children diagnosed with rheumatic disease: A single-center study</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Çakmak, Figen ; Akgün, Özlem ; Demirkan, Fatma Gül ; Tanatar, Ayşe ; Kayaalp, Gülşah Kavrul ; Keskindemirci, Gonca ; Guliyeva, Vafa ; Ömeroğlu, Rukiye Eker ; Gökçay, Emine Gülbin ; Ayaz, Nuray Aktay</creator><creatorcontrib>Çakmak, Figen ; Akgün, Özlem ; Demirkan, Fatma Gül ; Tanatar, Ayşe ; Kayaalp, Gülşah Kavrul ; Keskindemirci, Gonca ; Guliyeva, Vafa ; Ömeroğlu, Rukiye Eker ; Gökçay, Emine Gülbin ; Ayaz, Nuray Aktay</creatorcontrib><description>To evaluate the safety profile of measles, mumps and rubella (MMR) booster in children diagnosed with rheumatic diseases receiving biological agents. The study included retrospective safety data of children administered MMR booster dose receiving biologics or biologics with methotrexate. The files of 182 patients were accessed from the pediatric rheumatology biological therapy archive, and the vaccination status of these children was obtained by accessing electronic records. Of 182 patients, 14 patients were vaccinated with MMR booster dose. Thirteen of the patients were followed up with a diagnosis of juvenile idiopathic arthritis and one with colchicine-resistant familial Mediterranean fever. None of the patients had disease exacerbation after vaccination, and three patients had mild side effects consisting of rash, angioedema, joint pain, and fatigue.
Conclusion
: This study supports the data regarding evidence of the safety of MMR booster dose administration in children with rheumatic diseases receiving bDMARDs.
What is Known:
• MMR booster is avoided in immunocompromised pediatric patients receiving bDMARDs except in specific conditions.
What is New:
• The MMR booster dose may be safe in children with PedRD receiving bDMARDs or bDMARDs with MTX. These bullets can be added to the manuscript.</description><identifier>ISSN: 1432-1076</identifier><identifier>ISSN: 0340-6199</identifier><identifier>EISSN: 1432-1076</identifier><identifier>DOI: 10.1007/s00431-022-04646-x</identifier><identifier>PMID: 36224436</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Angioedema ; Antibodies, Viral - therapeutic use ; Arthralgia ; Arthritis ; Arthritis, Juvenile - drug therapy ; Child ; Children ; Colchicine ; Familial Mediterranean fever ; Humans ; Immunization ; Immunization, Secondary ; Infant ; Measles ; Measles - prevention & control ; Measles-Mumps-Rubella Vaccine - adverse effects ; Medicine ; Medicine & Public Health ; Methotrexate ; Methotrexate - therapeutic use ; Mumps ; Mumps - prevention & control ; Pediatrics ; Retrospective Studies ; Rheumatic diseases ; Rheumatology ; Rubella ; Rubella - prevention & control ; Safety ; Vaccination</subject><ispartof>European journal of pediatrics, 2023-01, Vol.182 (1), p.135-140</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c349t-81e312930e893e3d6020f8a428addfecd3d06861ae0205dff46d35d1e27226ba3</citedby><cites>FETCH-LOGICAL-c349t-81e312930e893e3d6020f8a428addfecd3d06861ae0205dff46d35d1e27226ba3</cites><orcidid>0000-0002-1667-2480 ; 0000-0001-9950-2489 ; 0000-0001-7490-7076 ; 0000-0002-1386-4575 ; 0000-0002-1663-015X ; 0000-0003-3594-7387 ; 0000-0001-7216-0562</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00431-022-04646-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00431-022-04646-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36224436$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Çakmak, Figen</creatorcontrib><creatorcontrib>Akgün, Özlem</creatorcontrib><creatorcontrib>Demirkan, Fatma Gül</creatorcontrib><creatorcontrib>Tanatar, Ayşe</creatorcontrib><creatorcontrib>Kayaalp, Gülşah Kavrul</creatorcontrib><creatorcontrib>Keskindemirci, Gonca</creatorcontrib><creatorcontrib>Guliyeva, Vafa</creatorcontrib><creatorcontrib>Ömeroğlu, Rukiye Eker</creatorcontrib><creatorcontrib>Gökçay, Emine Gülbin</creatorcontrib><creatorcontrib>Ayaz, Nuray Aktay</creatorcontrib><title>Live-attenuated measles, mumps, and rubella booster vaccine in children diagnosed with rheumatic disease: A single-center study</title><title>European journal of pediatrics</title><addtitle>Eur J Pediatr</addtitle><addtitle>Eur J Pediatr</addtitle><description>To evaluate the safety profile of measles, mumps and rubella (MMR) booster in children diagnosed with rheumatic diseases receiving biological agents. The study included retrospective safety data of children administered MMR booster dose receiving biologics or biologics with methotrexate. The files of 182 patients were accessed from the pediatric rheumatology biological therapy archive, and the vaccination status of these children was obtained by accessing electronic records. Of 182 patients, 14 patients were vaccinated with MMR booster dose. Thirteen of the patients were followed up with a diagnosis of juvenile idiopathic arthritis and one with colchicine-resistant familial Mediterranean fever. None of the patients had disease exacerbation after vaccination, and three patients had mild side effects consisting of rash, angioedema, joint pain, and fatigue.
Conclusion
: This study supports the data regarding evidence of the safety of MMR booster dose administration in children with rheumatic diseases receiving bDMARDs.
What is Known:
• MMR booster is avoided in immunocompromised pediatric patients receiving bDMARDs except in specific conditions.
What is New:
• The MMR booster dose may be safe in children with PedRD receiving bDMARDs or bDMARDs with MTX. These bullets can be added to the manuscript.</description><subject>Angioedema</subject><subject>Antibodies, Viral - therapeutic use</subject><subject>Arthralgia</subject><subject>Arthritis</subject><subject>Arthritis, Juvenile - drug therapy</subject><subject>Child</subject><subject>Children</subject><subject>Colchicine</subject><subject>Familial Mediterranean fever</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunization, Secondary</subject><subject>Infant</subject><subject>Measles</subject><subject>Measles - prevention & control</subject><subject>Measles-Mumps-Rubella Vaccine - adverse effects</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Methotrexate</subject><subject>Methotrexate - therapeutic use</subject><subject>Mumps</subject><subject>Mumps - prevention & control</subject><subject>Pediatrics</subject><subject>Retrospective Studies</subject><subject>Rheumatic diseases</subject><subject>Rheumatology</subject><subject>Rubella</subject><subject>Rubella - prevention & control</subject><subject>Safety</subject><subject>Vaccination</subject><issn>1432-1076</issn><issn>0340-6199</issn><issn>1432-1076</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kTtvFDEUhS1ERB7wByiQJRqKOPg13lm6KEoAaSUaqC2vfWfX0Yxn8bVDUvHX8bLhIQqqa-l85_jah5CXgl8IzhdvkXOtBONSMq6NNuz-CTkRWkkm-MI8_et8TE4Rb3kzLUX_jBwrI6XWypyQ76t4B8yVAqm6AoFO4HAEPKdTnXZtuBRormsYR0fX84wFMr1z3scENCbqt3EMGRIN0W3SjC3hWyxbmrdQJ1eibwK2SHhHLynGtBmBeUj7FCw1PDwnR4MbEV48zjPy5eb689UHtvr0_uPV5Yp5pZeF9QKUkEvFoV8qUMFwyYfeadm7EAbwQQVueiMcNKELw6BNUF0QIBdSmrVTZ-TNIXeX568VsNgpot-_KsFc0TZOd72WHW_o63_Q27nm1LZrlJFd-7yub5Q8UD7PiBkGu8txcvnBCm739dhDPbbVY3_WY--b6dVjdF1PEH5bfvXRAHUAsElpA_nP3f-J_QE0CJwx</recordid><startdate>20230101</startdate><enddate>20230101</enddate><creator>Çakmak, Figen</creator><creator>Akgün, Özlem</creator><creator>Demirkan, Fatma Gül</creator><creator>Tanatar, Ayşe</creator><creator>Kayaalp, Gülşah Kavrul</creator><creator>Keskindemirci, Gonca</creator><creator>Guliyeva, Vafa</creator><creator>Ömeroğlu, Rukiye Eker</creator><creator>Gökçay, Emine Gülbin</creator><creator>Ayaz, Nuray Aktay</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1667-2480</orcidid><orcidid>https://orcid.org/0000-0001-9950-2489</orcidid><orcidid>https://orcid.org/0000-0001-7490-7076</orcidid><orcidid>https://orcid.org/0000-0002-1386-4575</orcidid><orcidid>https://orcid.org/0000-0002-1663-015X</orcidid><orcidid>https://orcid.org/0000-0003-3594-7387</orcidid><orcidid>https://orcid.org/0000-0001-7216-0562</orcidid></search><sort><creationdate>20230101</creationdate><title>Live-attenuated measles, mumps, and rubella booster vaccine in children diagnosed with rheumatic disease: A single-center study</title><author>Çakmak, Figen ; Akgün, Özlem ; Demirkan, Fatma Gül ; Tanatar, Ayşe ; Kayaalp, Gülşah Kavrul ; Keskindemirci, Gonca ; Guliyeva, Vafa ; Ömeroğlu, Rukiye Eker ; Gökçay, Emine Gülbin ; Ayaz, Nuray Aktay</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c349t-81e312930e893e3d6020f8a428addfecd3d06861ae0205dff46d35d1e27226ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Angioedema</topic><topic>Antibodies, Viral - therapeutic use</topic><topic>Arthralgia</topic><topic>Arthritis</topic><topic>Arthritis, Juvenile - drug therapy</topic><topic>Child</topic><topic>Children</topic><topic>Colchicine</topic><topic>Familial Mediterranean fever</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunization, Secondary</topic><topic>Infant</topic><topic>Measles</topic><topic>Measles - prevention & control</topic><topic>Measles-Mumps-Rubella Vaccine - adverse effects</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Methotrexate</topic><topic>Methotrexate - therapeutic use</topic><topic>Mumps</topic><topic>Mumps - prevention & control</topic><topic>Pediatrics</topic><topic>Retrospective Studies</topic><topic>Rheumatic diseases</topic><topic>Rheumatology</topic><topic>Rubella</topic><topic>Rubella - prevention & control</topic><topic>Safety</topic><topic>Vaccination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Çakmak, Figen</creatorcontrib><creatorcontrib>Akgün, Özlem</creatorcontrib><creatorcontrib>Demirkan, Fatma Gül</creatorcontrib><creatorcontrib>Tanatar, Ayşe</creatorcontrib><creatorcontrib>Kayaalp, Gülşah Kavrul</creatorcontrib><creatorcontrib>Keskindemirci, Gonca</creatorcontrib><creatorcontrib>Guliyeva, Vafa</creatorcontrib><creatorcontrib>Ömeroğlu, Rukiye Eker</creatorcontrib><creatorcontrib>Gökçay, Emine Gülbin</creatorcontrib><creatorcontrib>Ayaz, Nuray Aktay</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Çakmak, Figen</au><au>Akgün, Özlem</au><au>Demirkan, Fatma Gül</au><au>Tanatar, Ayşe</au><au>Kayaalp, Gülşah Kavrul</au><au>Keskindemirci, Gonca</au><au>Guliyeva, Vafa</au><au>Ömeroğlu, Rukiye Eker</au><au>Gökçay, Emine Gülbin</au><au>Ayaz, Nuray Aktay</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Live-attenuated measles, mumps, and rubella booster vaccine in children diagnosed with rheumatic disease: A single-center study</atitle><jtitle>European journal of pediatrics</jtitle><stitle>Eur J Pediatr</stitle><addtitle>Eur J Pediatr</addtitle><date>2023-01-01</date><risdate>2023</risdate><volume>182</volume><issue>1</issue><spage>135</spage><epage>140</epage><pages>135-140</pages><issn>1432-1076</issn><issn>0340-6199</issn><eissn>1432-1076</eissn><abstract>To evaluate the safety profile of measles, mumps and rubella (MMR) booster in children diagnosed with rheumatic diseases receiving biological agents. The study included retrospective safety data of children administered MMR booster dose receiving biologics or biologics with methotrexate. The files of 182 patients were accessed from the pediatric rheumatology biological therapy archive, and the vaccination status of these children was obtained by accessing electronic records. Of 182 patients, 14 patients were vaccinated with MMR booster dose. Thirteen of the patients were followed up with a diagnosis of juvenile idiopathic arthritis and one with colchicine-resistant familial Mediterranean fever. None of the patients had disease exacerbation after vaccination, and three patients had mild side effects consisting of rash, angioedema, joint pain, and fatigue.
Conclusion
: This study supports the data regarding evidence of the safety of MMR booster dose administration in children with rheumatic diseases receiving bDMARDs.
What is Known:
• MMR booster is avoided in immunocompromised pediatric patients receiving bDMARDs except in specific conditions.
What is New:
• The MMR booster dose may be safe in children with PedRD receiving bDMARDs or bDMARDs with MTX. These bullets can be added to the manuscript.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>36224436</pmid><doi>10.1007/s00431-022-04646-x</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-1667-2480</orcidid><orcidid>https://orcid.org/0000-0001-9950-2489</orcidid><orcidid>https://orcid.org/0000-0001-7490-7076</orcidid><orcidid>https://orcid.org/0000-0002-1386-4575</orcidid><orcidid>https://orcid.org/0000-0002-1663-015X</orcidid><orcidid>https://orcid.org/0000-0003-3594-7387</orcidid><orcidid>https://orcid.org/0000-0001-7216-0562</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1432-1076 |
| ispartof | European journal of pediatrics, 2023-01, Vol.182 (1), p.135-140 |
| issn | 1432-1076 0340-6199 1432-1076 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2724584250 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Angioedema Antibodies, Viral - therapeutic use Arthralgia Arthritis Arthritis, Juvenile - drug therapy Child Children Colchicine Familial Mediterranean fever Humans Immunization Immunization, Secondary Infant Measles Measles - prevention & control Measles-Mumps-Rubella Vaccine - adverse effects Medicine Medicine & Public Health Methotrexate Methotrexate - therapeutic use Mumps Mumps - prevention & control Pediatrics Retrospective Studies Rheumatic diseases Rheumatology Rubella Rubella - prevention & control Safety Vaccination |
| title | Live-attenuated measles, mumps, and rubella booster vaccine in children diagnosed with rheumatic disease: A single-center study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T07%3A18%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Live-attenuated%20measles,%20mumps,%20and%20rubella%20booster%20vaccine%20in%20children%20diagnosed%20with%20rheumatic%20disease:%20A%20single-center%20study&rft.jtitle=European%20journal%20of%20pediatrics&rft.au=%C3%87akmak,%20Figen&rft.date=2023-01-01&rft.volume=182&rft.issue=1&rft.spage=135&rft.epage=140&rft.pages=135-140&rft.issn=1432-1076&rft.eissn=1432-1076&rft_id=info:doi/10.1007/s00431-022-04646-x&rft_dat=%3Cproquest_cross%3E2762536258%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2762536258&rft_id=info:pmid/36224436&rfr_iscdi=true |